Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 7/24/2024Pfizer China President Praises China 's Reforms for Boosting Innovatio...
  • 7/24/2024CDE Solicits Public Comments on the Guidelines for Setting Limits on R...
  • 7/24/2024CDE Solicits Public Comments on the Technical Guideline for the Study ...
  • 7/23/2024CCP Pledges "Health-First Strategy" for Medical and Healthcare Reform
  • 7/23/2024Global Drugmakers Pursue Deals in China Despite Tensions
  • 7/23/2024NHSA Issues the DRG and DIP Grouping Plans V2.0
  • 7/23/2024Aligos Partners with Xiamen Amoytop Biotech for New CHB Treatment Stud...
  • 7/23/2024Triastek Announces Research License Deal with BioNTech to Advance 3D P...
  • 7/23/2024Fosun and Kite Pharma Agree to Convert Debt to Equity, Increasing JV F...
  • 7/22/2024Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug
  • 7/22/2024Innovent's Lilly-Partnered Type 2 Diabetes Drug Succeeds in Phase III ...
  • 7/22/2024Wantai, GSK Terminate HPV Vaccine Development Deal
  • 7/19/2024Recent Executive Moves
  • 7/19/2024Chinese and Visiting Japanese Top Healthcare Officials Agree to Promot...
  • 7/19/2024Beijing to Build International Pharma Innovation Park
  • 7/19/2024CDE Solicits Public Comments on the Technical Guidelines for In Vitro ...
  • 7/19/2024NHSA: DRG Grouping V2.0 to Be Released, Policy Tilt Towards Innovative...
  • 7/19/2024Eli Lilly Wins Label Expansion for Tirzepatide in China
  • 7/19/2024Exscientia Acquires Full Control of CDK7 Drug, Plans Breast Cancer Com...
  • 7/19/2024Rona Thera Raises $35M Series A+ Financing to Advance Innovative Metab...
  • 7/19/2024ExoNeuglia Secures Investment to Advance Clinical Trials for Neurodege...
  • 7/18/2024China Sets Up National Working Group to Standardize Healthcare Securit...
  • 7/18/2024Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...
  • 7/18/2024Marinus's Ganaxolone Approved in China as First Treatment for Seizures...
  • 7/18/2024India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
  • 7/18/2024NMPA Suspends Import, Sales and Use of Daiwoong's Cefodizime Sodium fo...
  • 7/18/2024NMPA Solicits Public Comments on Drafts of the 'GMP for Pharmaceutical...
  • 7/17/2024CDE Issues the Technical Guidelines for Clinical Trials of Drugs for G...
  • 7/17/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 7/17/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • Page:46/51 Total number of articles:1501: [First][<<] [44] [45] [46] [47] [48] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group